i-Ome™ Discovery is Sengenics’ most advanced protein microarray, meticulously designed for antibody and autoantibody profiling in biomarker discovery. This powerful platform delivers key insights into ...

In a recently published Scientific Reports paper, scientists determined that specific microRNAs (miRNA) detected within blood samples could serve as potential diagnostic and predictive biomarkers ...

We will show how tissue microarrays have become ... and enforced to aid validation of biomarkers and collaboration. Clinical trials on four main antibodies, tremelimumab, bevacizumab, ipilimumab ...

In their proof-of-concept study, the researchers have built sensors that combined the ability to detect COVID-19-specific ...

Proteomics, with its power to measure the expression level of multiple proteins and their modifications, currently plays a major role in cancer biomarker discovery. Generally, proteomics includes ...

antibodies. For each PamChip®, 4 separate samples can be assayed since each of the wells contains the peptide substrate microarray surveying the tyrosine kinome (PTK) or serine/threonine (STK) kinome.

The effective implementation of personalised cancer therapeutic regimens depends on the successful identification and translation of informative biomarkers to aid clinical decision-making.